Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Int J Dermatol ; 61(11): 1390-1396, 2022 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-35726457

RESUMEN

BACKGROUND: F2-isoprostane is one of the members of biologically active prostaglandins. It is considered a reliable marker of oxidative stress. This study aimed at investigating and studying the hypothesis of the possible role of prostaglandin F2-alpha (PGF2α) in the pathogenesis of vitiligo and to know if there is a possibility of using it in therapy. METHODS: This case-control study involved 30 patients with nonsegmental vitiligo and 30 healthy sex- and age-matched controls over a period of 7 months. Skin biopsies were taken from lesional and nonlesional vitiliginous skin of patients and from normal skin of controls for measurement of PGF2α in tissue by ELISA. RESULTS: The tissue levels of PGF2α in vitiligo patients were significantly higher in both lesional and nonlesional skin than in healthy controls (P < 0.001). The tissue levels of PGF2α in lesional skin were significantly higher than in nonlesional skin (P < 0.001). CONCLUSION: Based on the fact that PGF2α is a reliable biomarker of oxidative stress, in addition to our results that revealed higher tissue levels of PGF2α in vitiliginous skin than in healthy skin, we can conclude that PGF2α may be incriminated in the pathogenesis of vitiligo. This finding could help in the treatment of this disease by using anti-PGF2α drugs.


Asunto(s)
Vitíligo , Estudios de Casos y Controles , Dinoprost , F2-Isoprostanos , Humanos , Lactante , Piel/patología , Vitíligo/patología
3.
Australas J Dermatol ; 58(2): e36-e39, 2017 May.
Artículo en Inglés | MEDLINE | ID: mdl-26437741

RESUMEN

Proopiomelanocortin (POMC) and melanocortin 1 receptor (MC1R) are regulators of melanogenesis and pigmentation. Our objective was to estimate their levels, searching for a possible role of the melanocortin system in vitiligo. This study included 40 vitiligo patients and 40 controls. Skin biopsies were taken from lesional and non-lesional skin of patients and from the non-sun exposed skin of controls to detect the expression of POMC and MC1R using quantitative real-time polymerase chain reaction. Both factors were significantly lower in lesional than non-lesional skin and controls, while they were significantly higher in non-lesional skin than in controls. There was a statistically significant positive correlation between lesional levels of POMC and MC1R, as well as between non-lesional levels of POMC and MC1R in the patients. On the other hand, we found a statistically significant negative correlation between the lesional and non-lesional levels of POMC, as well as between the lesional and non-lesional levels of MC1R in the patients. As a conclusion, the melanocortin system could play a role in the pathogenesis of vitiligo or could be affected as the end result of the disease.


Asunto(s)
Proopiomelanocortina/genética , Receptor de Melanocortina Tipo 1/genética , Vitíligo/genética , Adolescente , Adulto , Anciano , Estudios de Casos y Controles , Niño , Femenino , Expresión Génica , Humanos , Masculino , Persona de Mediana Edad , Piel , Vitíligo/patología , Adulto Joven
4.
J Cosmet Dermatol ; 8(4): 275-81, 2009 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-19958431

RESUMEN

BACKGROUND: Chemical peels and topical depigmenting agents have become a popular modality in the treatment of melasma. AIMS: To compare the clinical efficacy of trichloroacetic acid peel 20%vs. Jessner's solution peel vs. the topical mixture of hydroquinone 2% and kojic acid. PATIENTS AND METHODS: Forty five patients with melasma were randomly assigned into three groups of fifteen patients each. Group A received Jessner's solution peel, group B received trichloroacetic acid peel 20%, and group C received topical hydroquinone 2% and kojic acid. All patients were seen in follow-up period after 16 weeks; clinical evaluation using Melasma Area and Severity Index (MASI) score and photography were recorded before and after treatment and after 16 weeks. RESULTS: There was a decrease in MASI score in all three groups after treatment and after follow-up period but after treatment MASI score was statistically significantly lower in group A than group C (P = 0.01), and it was also statistically significantly lower in group B than group C (P < 0.001) but there was no statistically significant difference between groups A and B. After the follow-up period, MASI score was statistically significantly lower in group A than group C (P < 0.001), statistically significantly lower in group B than group C (P < 0.001), and statistically significantly lower in group B than group A (P = 0.035). The statistical analysis was done through one-way anova followed by least significant difference (LSD). CONCLUSION: Trichloroacetic acid 20% showed better results than Jessner's solution as peeling agent and hydroquinone 2% with kojic acid as a topical agent in the treatment of melasma.


Asunto(s)
Etanol/administración & dosificación , Hidroquinonas/administración & dosificación , Queratolíticos/administración & dosificación , Ácido Láctico/administración & dosificación , Melanosis/terapia , Pironas/administración & dosificación , Resorcinoles/administración & dosificación , Salicilatos/administración & dosificación , Ácido Tricloroacético/administración & dosificación , Administración Tópica , Adulto , Combinación de Medicamentos , Femenino , Humanos , Persona de Mediana Edad , Estudios Prospectivos , Método Simple Ciego , Adulto Joven
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...